Obesity is complicated. This metabolic disease has genetic, environmental and psychological factors, and is associated with multiple chronic conditions and poorer mental health outcomes. And, bias and stigma can get in the way of a successful workplace strategy. The economic burden to employers is significant. A new generation of anti-obesity drugs has shifted the treatment landscape, creating both a challenge and opportunity for employers. Employers attending this session will gain a better understanding of the latest research, employer best practices and concrete ideas to mitigate costs associated with obesity.
This program is available both in-person and virtually.